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Abstract 
The properties of the binding of annexin V to variously composed phospholipid vesicles have been studied by applying a recently 
developed EPR method, using an annexin V spin label. By this approach, this protein is seen to bind to acidic phospholipid-containing 
vesicles, as reported, thus confirming the reliability of the method. In addition, binding of this annexin to cardiolipin-containing vesicles 
has been studied in more depth, and the protein has been shown to have a distinct affinity for this phospholipid. As a cardiolipin-rich 
natural membrane system, mitochondrial membranes and mitoplasts from rat liver were considered, and a strong binding of AV to these 
membranes was observed. Having compared this binding with that to phospholipid vesicles, cardiolipin-rich microdomains in the 
mitochondrial membranes are proposed as the putative mitochondrial binding sites for annexin V. 
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1. Introduction 
The calcium-dependent binding of annexins [1] to mem- 
brane acidic phospholipids appears to be the key step to 
the onset of the various well documented biological effects 
exerted by these proteins, such as the inhibition of 
phospholipase A 2, anticoagulatory activity, exocytosis, 
calcium channelling and others [1]. Nonetheless, system- 
atic studies of the interaction of each annexin with differ- 
ent phospholipid classes are scarcely represented in the 
literature [2,3]. This paper is a first step in an attempt o 
define the phospholipid affinity pattern of each annexin, 
which, in turn, will help to establish whether or not the 
different proteins are membrane specific. According to the 
phospholipid composition of a given membrane (or a given 
membrane microdomain), this definition might provide a 
Abbreviations: EPR, electron paramagnetic resonance; AVSL, an- 
nexin V spin label; SUV, small unilamellar vesicle; LPV, large phospho- 
lipid vesicles; RLM, rat liver mitochondria; FCCP, carbonyl cyanide 
p-(trifluoromethoxy)phenylhydrazone; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PA, phosphatidic acid; PI, phosphatidyl- 
inositol; PS, phosphatidylserine; DPG, diphosphatidylglycerol (cardioli- 
pin). 
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clue to the possibility of a sort of targeting of each annexin 
in a cell to a particular subcellular membrane (or mem- 
brane microdomain). This possibility may help in under- 
standing the observed variability of the annexin ensemble 
present in all tissues studied to date [1]. 
Following this reasoning, this paper considers in more 
depth the previously observed binding of annexin V (from 
bovine lung) spin label (AVSL) to isolated rat liver mito- 
chondria [4], in comparison with the binding of this spin 
label to variously composed liposomes (SUVs). Beyond 
the acidic phospholipids previously studied [2,3,5], cardi- 
olipin, an important mitochondrial phospholipid [6] and a 
well known modulator of functionally important mitochon- 
drial enzymes [7], has been specifically investigated. Our 
results indicate that AV binds to acidic phospholipids, as 
already established by different methods [2,5], and that, 
accordingly, optimal Ca-regulation of this binding occurs 
between 10 and 0.1 /zM Ca 2+. In addition, a high binding 
affinity of AV for cardiolipin-rich liposomes has been 
observed; moreover, such liposomes prove to be the only 
ones to undergo aggregation following AV binding. Appli- 
cation of the EPR method to the study of the interaction of 
AV with mitochondrial membranes, revealed a fair Ca-de- 
pendent binding ability of these membranes towards the 
protein. Finally, the present results indicate that cardiolipin 
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is probably the main lipid component of the mitochondrial 
annexin binding site. 
2. Materials and methods 
2.1. Protein preparation 
Annexin V (p34) was isolated and purified from beef 
lung as described elsewhere [5,8]. The spin labeling proce- 
dure, using 3-(2-iodoacetamido)-2,2,5,5-tetramethylpyrro- 
lidinyl-N-oxyl (iodoacetamidoproxyl, A drich) has also 
been outlined previously [4,8]. Protein content was assayed 
by the Bradford method [9]. 
2.2. Phospholipid vesicles 
Liposomes (SUVs) were prepared by ultrasonic irradia- 
tion of phospholipid suspensions in 125 mM KC1/2.5 mM 
MGC12/25 mM Hepes (pH 7.4) (Buffer B), at 40 W output 
(three or four 5 min strokes, intercalated with 1 min 
cooling intervals) in an ice bath under N 2. In some in- 
stances, these preparations were further subjected to 
Sepharose 4B chromatography [10], and control experi- 
ments were mn separately with either the first or the 
second eluting peak (larger and smaller phospholipid vesi- 
cles, respectively). Phospholipid phosphorus was assayed 
according to Nakamura [11]. 
2.3. Mitochondrial membranes 
Mitochondria were prepared according to Hogeboom 
[12] from freshly excised rat livers, in 0.25 M sucrose/10 
mM Tris-HC1 (pH 7.4). In order to suppress reductive 
side-effects by the organelles on the spin labeled protein, 
the former were resuspended in Buffer B and subjected to 
30 min incubation at 37 ° C in the presence of 2 /zM FCCP 
and air, as described [4]. This preparation contained 20-30 
/xM Ca 2÷, as previously determined by atomic absorption 
[4]; this amount was taken into account in calculating the 
final concentrations of Ca-EGTA buffers yielding the de- 
sired experimental free pCa [13]. 
Delipidated mitochondria were obtained by treating this 
preparation with acetone and ammonia, as described by 
Fleischer and Fieischer [14,15]. 
Mitoplasts were also prepared from the starting mito- 
chondrial fraction, by digitonin treatment according to 
Greenawalt [ 16]. 
Purification of isolated mitochondria from accompany- 
ing peroxisomes and lysosomes was accomplished by cen- 
trifugation on a Percoll density gradient [ 17]. The purity of 
the preparation was checked by assaying the marker en- 
zymes of peroxisomes (catalase) and lysosomes (acid 
phosphatase) as described [18,19]. Mitochondrial protein 
was determined by the Biuret method. 
2.4. EPR spectrometry and A VSL binding assay 
The binding of AVSL to membranes was measured by 
EPR spectroscopy, as described in a previous paper [4]. 
Briefly, 40/xl samples in 100 mM KCI/2 mM MgC12/20 
mM Hepes (pH 7.4) (Buffer A), containing up to 300 nmol 
SUV (as phospholipid phosphorus), 10-15 /~g AVSL and 
variable calcium and EGTA concentrations, depending on 
the desired free Ca 2+ concentration [13], were incubated 
for 10 min at room temperature and transferred into glass 
capillaries. Binding to variously treated mitochondria was 
measured on similar samples in which the SUVs were 
replaced by 50-500 /xg mitochondrial protein. EPR spec- 
tra were recorded by means of a Varian E-Line ESR 
spectrometer, coupled to an HP 9835B desk computer 
through the Varian Data Acquisition System. Instrumental 
settings were: 3396-G field set, with 200-G scan range; 
100 kHz and 2 G modulation frequency and amplitude, 
respectively; 20 mW and 9.5 GHz radiating field power 
and frequency, respectively; 1/1.6.104 gain; 0.5/2 s 
time constant; and 30/120 min scan time. 
Quantitation of the bound AVSL percentage was 
achieved as previously described [4]. In summary, the 
method requires the following measurements: as a first 
step, the EPR spectra of the fully bound/unbound AVSL 
(in the presence of either 1 mM Ca 2 ÷ or 10 mM EGTA, 
respectively) are recorded, and the two sets of bandwidths 
are estimated for the two specimens. As a second step, the 
EPR spectrum of the sample(s) in given conditions is 
recorded, and the rotational correlation time [20], ~'c, evalu- 
ated [21]. Finally, the bound AVSL percentage, q, is 
calculated [4] by solving the equation: 
"c~, = c{I U IB/ [  I B - -  q( l B - -  1U)] 
+ KuKB/ [  KB - q( KB -- Ku) ] 
-2gugB/ [  JB -- q( gB -- gu)]} 
where capital I, J, K stand for the above-cited set of 
low-, mid- and high-field bandwidths, with suffixes U and 
B indicating the unbound and bound AVSL, respectively, 
and c is a constant dependent on the particular spin label 
used. The theoretical background and experimental proce- 
dure of this method are given in Ref. [4]. 
2.5. Vesicle aggregation 
SUV aggregation promoted by AV was observed by 
phase-contrast microscopy [2]. Each 25 /zl sample con- 
tained 50 nmol phospholipid vesicles, 10 /zg AV and 0.1 
mM CaCI 2 in Buffer A. In the case of turbidity develop- 
ment, the sample was centrifuged, and after phase-contrast 
observation, one drop of 100 mM EGTA was added to the 
pellet directly on the glass slide using a microsyringe. 
Measurement of aggregation was performed spectrophoto- 
metrically [2] by means of a Beckman DU-8 spectro- 
photometer. 0 5 ml cuvettes contained 0.35 ml final vol- 
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ume samples in Buffer A, comprising 100 nmol vesicle, 
and 15 /zg annexin. The absorbance of the samples was 
monitored at 350 nm, a value outside the annexin absorp- 
tion band and the closest to 300 rim, the wavelength 
commonly used in spectrophotometrical studies of SUVs 
[10,22]. After recording the absorbance for 1-2 min, cal- 
cium was added to a final concentration of 0.1 mM. The 
absorbance increase was monitored in time until a constant 
value was reached, and then EGTA, at a final 10 mM 
concentration, was added. 
3. Resu l ts  
Fig. 1 shows the percentage binding of AVSL to vari- 
ously composed SUVs upon variable calcium concentra- 
tion, as determined by the method previously outlined [4]. 
From Fig. I A, the maximum binding of the protein to 
SUVs made up of PC and PS (1:1 mol ratio) at pCa 3 (1 
mM free Ca 2+) can be seen to decrease, with increasing 
pCa, with modulation of the binding by the cation in the 
pCa range between 6 and 8 (free Ca 2+ concentration 
1-0.01 #M). Binding of AVSL to PI- and PE-containing 
SUVs (in a 1:i molar ratio mixture with PC), whilst 
apparently high at pCa 3, is seen to drop to negligible 
values at higher pCa, with no Ca-modulation features. The 
results in Fig. 1B show the behaviour of 50% PA- or 
DPG-containing SUVs to be similar to that of those con- 
taining PS, with a Ca-regulated binding range between 
pCa values of 5 and 7 (10 and 0.1 mM free Ca 2+ 
concentration). In addition, from the same figure, it can be 
seen that lowering the acidic phospholipid content in the 
vesicles from 50% to 10% is reflected in a lower AVSL 
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Fig. 1. Percentage binding of AVSL to variously composed SUVs as a 
function of Ca concentration (pCa = - log[Ca 2+ ]). Phospholipid vesicles 
were made up of 1:1 mole ratio mixtures of (A) : . ,  PS/PC; - ,  H /PC;  
A, PE/PC; (B) PA/PC in a molar ratio of either, II, 1:1, or, n ,  1:9; 
DPG/PC either, O, 1:1; or, ©, 1:9 molar ratio. Vesicle amount in each 
experiment was 27.5 nmol SUV phospholipid phosphorus per/xg AVSL. 
10 to 15 /~,g annexin was incubated. More experimental details are given 









o 10 20 30 
SUV/AVSL (nmol/ug) 
Fig. 2. Percentage binding of AVSL to variously composed SUVs with 
variable membrane amounts, at pCa 3 and pCa 6, as indicated. PC and 
either, v ,  PS, or, m, PA; or, O, DPG, 1:1 molar ratio; (3, PC/DPG, 1:9 
molar ratio. The variable membrane amount is expressed as nmol SUVs 
per /xg incubated annexin (SUV/AVSL); other experimental conditions 
were as in Fig. 1. 
binding ability of these membranes. This effect is particu- 
larly evident for cardiolipin-containing SUVs. 
Fig. 2 reports the dependence on vesicular membrane 
availability (expressed as the nmol SUV to /zg AVSL 
ratio), of the percentage of AVSL binding to vesicles made 
of 50% PC and either PS, PA, or DPG (1:1 mol ratio). 
This figure, at pCa 3, shows that DPG-containing SUVs, 
bind 100% AVSL at a ratio of approx. 5 nmol//zg 
SUV/AVSL, whilst PA- and PS-containing vesicles bind 
the same annexin percentage at approx. 15 nmol /#g.  In 
the same figure, at pCa 6, the SUV amount yielding the 
maximal percent binding (Fig. 1, pCa 6) is unchanged for 
DPG and is somewhat higher (20 nmol//zg) for PA and 
PS. Referring to pCa 3 and 100% binding, it can be 
calculated that approximately 170 nmol DPG-SUVs binds 
1 nmol AVSL, whilst more than 500 nmol PA- or PS-SUVs 
is required to bind the same annexin amount. From the 
data at pCa 6, equivalent requirements of 280, 850 and 
1700 nmol SUV per nmol annexin can be estimated for 
DPG, PS and PA, respectively, to reach maximal binding. 
The aggregation of SUVs promoted by AV, was first 
observed visually in the EPR capillaries and then detected 
by phase-contrast microscopy on 50% DPG-containing 
SUVs or LPVs. In the presence of 0.1 mM Ca 2+, aggre- 
gates of either vesicle type were clearly visible; the forma- 
tions readily disappeared when EGTA was added. More 
precisely, vesicle aggregation was studied by spectrophoto- 
metrically measuring the consequent change in turbidity of 
the SUVs as the variation of optical density at 350 nm 
(Fig. 3), similar to as described elsewhere [2]. As can be 
seen, upon addition of final 0.1 mM Ca 2÷, only cardi- 
olipin-containing SUVs (a) undergo aggregation by AV, 
while vesicles containing the other binding acidic phospho- 
lipids (b and c) remain unaffected [2]. Noteworthy from 
this figure is that this distinctive feature of DPG-SUVs is 
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Fig. 3. Rate of Ca-induced aggregation of variously composed SUVs in 
the presence of AV. PC and either (a) DPG, (b) PA, or (c) PS, 1 : 1 molar 
ratio. (d) DPG/PC, 1:9 molar ratio. 
seen to vanish when the phospholipid content herein is 
lowered to 10% (d). Another important result in this figure 
is the apparent full reversibility of the Ca-induced effect 
upon addition of final 10 mM EGTA. 
Binding of AVSL to mitochondrial membranes was 
studied by using a mitochondrial fraction purified from 
peroxisomes and lysosomes by centrifugation on a Percoll 
density gradient. The respiratory activity of the preparation 
was also blocked, as described. The calcium dependence 
of AVSL binding to purified rat liver mitochondrial mem- 
branes, under various conditions, is reported in Fig. 4. The 
membranes bind 100% AVSL at pCa 3 (1 mM free Ca 2÷ ) 
and a ratio of mitochondrial protein/AVSL of 24:1 
(/zg//zg). The binding percentage gradually decreases 
with increasing pCa, with optimal Ca-regulated binding 
range comprised between pCa 5 and pCa 7 (10 to 0.1 /xM 
free Ca2+). Binding is still visible when the mito- 
chondria/AVSL ratio is lowered to 3:1, even if a limiting 
effect of the incubated membrane amount is evident. On 
the contrary, from the same figure, it is seen that the 
delipidated mitochondrial preparation [6,23], incubated at a 
24:1 ratio to the protein, does not respond at all to the 
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Fig. 4. Percentage binding of AVSL to purified mitochondria with 
variable Ca 2+ concentration (pCa). Ratio of mitochondrial protein to 
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Fig. 5. Percentage binding of AVSL to variously treated mitochondrial 
membranes with variable membrane amounts. The incubated membrane 
amount is expressed asthe ratio (/xg//zg) of mitochondrial protein to 
annexin (mitochondrial protein/annexin ratio). Untreated mitochondria at 
either pCa 3 (.) or pCa 6 (11). Mitoplasts, pCa 3 (&). Lipid-depleted 
mitochondria, pCa 3 (•). 
The AVSL binding ability of the variously treated 
mitochondrial membranes was compared by studying the 
dependence of AVSL binding percentage upon the incu- 
bated amount of each membrane preparation. The results 
are reported in Fig. 5. From this figure it is seen that the 
maximum annexin binding, at pCa 3, to both mitochondria 
and mitoplasts occurs at a minimum ratio (/xg mitochon- 
drial protein//xg AVSL) of 10-20:1. At pCa 6, binding is 
still operative, with a maximum binding ratio shifted to 
somewhat higher values (20-30:1 /xg//xg), while delipi- 
dated mitochondrial membranes, as shown, are no longer 
able to bind AVSL at any ratio. 
4. Discussion 
In comparison with other methods for studying the 
Ca-mediated binding of AV to acidic phospholipids [3,5], 
the EPR methodology previously presented [4] proves to 
be more advantageous in directly monitoring the binding, 
without further handling of the incubated samples [23,24]. 
From this aspect, the EPR method is similar to more 
recently developed methods [25-27]. Its reliability is con- 
firmed by the binding profile of AVSL to acidic phospho- 
lipids with variable pCa (Fig. 1). This fits very well the 
already reported AV binding properties [2,5]; as an exam- 
ple, 50%-PI LPVs are reported to bind AV only at 1 mM 
Ca 2+. As the only exception we found PE, which, unlike 
the others, is zwitterionic at the experimental pH. 
In the same figure, more detail appear about AV bind- 
ing to DPG. In fact, contrarily to what observed for PA, a 
high molar ratio of DPG seems to be critical for the 
annexin binding in the whole pCa range tested. This 
observation strongly indicates a peculiar affinity of AV for 
cardiolipin-rich membranes or, at least, membrane mi- 
crodomains. In addition, even if PA, PS and DPG appear 
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to be the most effective in annexin binding at physio- 
logical pCa, estimation of the binding molar ratio from the 
results reported in Fig. 2, allow the conclusion that cardi- 
olipin-containing SUVs have an approximately three-fold 
binding affinity (ca. 170 nmol SUV per nmol AVSL) with 
respect to PA and PS (ca. 510 nmol SUV per nmol 
AVSL), at pCa 3, and even more at physiological pCa. 
The figure of 510 nmol SUV per nmol AVSL for the 
binding molar ratio for PS-SUVs, estimated from Fig. 2, is 
very close to the one estimated by other authors [26] for 
20% PS-containing vesicles at pCa 3 (ca. 400 nmol vesi- 
cles per nmol AV), by using a fluorescence-labeled AV.
The high binding affinity of DPG for AV has already been 
observed [29]. An explanation might be the presence of an 
additional distinct phosphate group in its polar head, in 
comparison with the additional carboxyl group of PS, and 
the second negative charge (partial, at neutral pH) on the 
single phosphate group of PA. 
Whilst most annexins promote vesicle aggregation, AV 
is reportedly non-aggregating towards the commonly stud- 
ied acidic phospholipids [2,25,28]. Accordingly, our results 
(Fig. 3) confirm no aggregation of PA- and PS-SUVs, 
while strongly evidencing the occurrence of DPG-SUVs 
aggregation after calcium addition, in the presence of AV. 
The EGTA-dependent abolition of the absorbance increase 
rules out vesicle fusion, whilst control runs excluded any 
side-effect by calcium alone. Moreover, failure of AV in 
aggregating 10% DPG-containing SUVs is in keeping with 
the above results, further arguing in favour of a peculiar 
relationship of cardiolipin-rich membranes (or membrane 
microdomains) with AV. 
Binding of AV to cardiolipin-containing bilayers has 
already been reported [29-31]. This annexin showed the 
highest affinity for planar bilayers in the mM Ca 2+ con- 
centration range [29], and for LPVs between 1 and l0/xM 
Ca 2+ [3]. Our results, obtained with SUVs, a third and 
again different membrane system, resemble more those 
from LPVs, most probably due to their similar vesicular 
shape. With these membranes, modulation of AV binding 
occurs via both the DPG content and the Ca 2+ concentra- 
tion in a range (0.1-10 /zM) considered functionally im- 
portant for AV binding in the living cell [29]. 
These considerations prompted the study of the interac- 
tion of AV with mitochondria, the most cardiolipin-rich 
membrane in the cell, using the EPR method which, as 
stated above, is particularly well-suited to studies involv- 
ing natural membranes [23,24,38]. As an additional reason, 
few studies have appeared ealing with natural membrane 
binding of annexins [32-37]. From the present study, 
mitochondrial membranes show a strong ability of AVSL 
binding at pCa 3 and exhibit a well-characterized Ca-mod- 
ulated binding profile upon increasing pCa, with optimal 
modulation in the physiological pCa range (Fig. 4, pCa 
5-7). Whilst lowering the RLM to AVSL ratio from 24:1 
to 3:1 (/zg//xg) only shows an expectable limiting effect 
of membrane availability, delipidation of mitochondria (  
well established method, useful to decide the role of the 
phospholipid component in membrane biochemistry, 
[6,14,15]) results in no binding at all, even at the maximum 
binding-ratio for untreated mitochondria, i.e., 24:1. This 
behaviour confirms the phospholipid component of the 
mitochondrial membrane as being responsible for the bind- 
ing of AV. In more detail, by considering the phospholipid 
composition of rat liver mitochondria [6], it can be seen 
that, amongst he significantly represented phospholipids, 
only DPG is capable of AV binding. Thus, the reported 
absence of PA and PS suggests that failure in AVSL 
binding to lipid-depleted mitochondrial membranes (Fig. 
4) should be ascribed to removal of cardiolipin. Further- 
more, comparison of the profile and extent of AVSL 
binding to mitochondrial membranes with those to the 
SUVs (Fig. 1), particularly in the physiological calcium 
concentration range, favours attribution of the mitochon- 
drial AVSL binding capacity to DPG-rich microdomains. 
Mitoplasts exhibit essentially the same AVSL binding 
affinity as the whole mitochondrial membranes, ince both 
preparations appear to reach quasi-maximal binding (90%) 
at the same membrane to AVSL ratio of 10 /~g per /zg 
spin labeled annexin V (Fig. 5). This result was to be 
expected on the basis of the cardiolipin content of the 
inner mitochondrial membrane, confirming that these 
membranes owe their AV binding ability to the presence 
of the phospholipid. The decrease in the binding of mito- 
chondria (and mitoplasts, not shown) to about 50% at pCa 
6 (compatible with the value expected from Fig. 4), com- 
pared with the negligible binding of AV to PE and PI at 
the same pCa value (see Fig. 1A), confirms the correct 
attribution of the observed binding to DPG. In addition, 
the observed binding to mitoplasts uggests that rupture of 
the outer membrane, possibly provoked by prolonged han- 
dling during the purification and respiration steps, does not 
detract from our results. However, due to asymmetrical 
transmembrane DPG distribution [6] and different 
phospholipid/protein mass ratio in the mitochondrial 
membranes [16], these data are not suited to give quantita- 
tive assessments of the phenomenon observed. 
In conclusion, the data presented indicate a peculiar 
affinity of AV for cardiolipin, and suggest that this protein 
might be targeted to mitochondria via this phospholipid in 
the living cell. Targeting of annexins to membranes (or 
membrane subdomains), via the phospholipid composition, 
has already been proposed [30], as has the possibility of a 
regulatory role of bound annexins on membrane proteins 
[30,31]. Our results show that the Ca 2+ concentration i
the living cell is appropriate for AV binding to DPG-rich 
curved bilayers, in contrast with what has been reported 
for 20% DPG-containing planar bilayers [29]. In this con- 
text, the similarity between the cardiolipin requirements 
for the optimal functioning of many important mitochon- 
drial enzymes [39-43] and those for AV binding to mito- 
chondria, raises interesting ideas worthy of further investi- 
gation. 
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